It is our pleasure to invite you to the inaugural Summit on Controversies in Precision Medicine which will take place in Berlin 13-15 November 2017.
The Summit, under the leadership of Professor Dan Peer, Director of Tel Aviv University Cancer Biology Research Center and Translational Medicine, will explore in a realistic, non-biased manner global issues facing the community (clinicians, scientists, pharmaceutical industries and patients) that wants to build on the promise of Precision Medicine. By using plenary talks, scientific debates, and discussions, we will look at future ways to increase the productivity of biopharmaceutical and clinical innovation, with examples in oncology and rare diseases.
This year’s summit is titled, “Where do we stand in drug development?” to create a focused environment for quality and open scientific debate on the value and direction of the industry. With an interactive architecture, the event is designed to provide the participants with exciting opportunities to ignite solutions, network and innovate.
Become part of 150+ senior level attendees from leading industry companies, academia and government institutions who have put innovation in their pipeline.
If you are eager to explore strategies for addressing challenges and igniting solutions in Precision Medicine, join us this November in Berlin!
Hoping to see you all there,
The Scientific Advisory Board
Prof. Dan Peer, Israel
Christian Elze, London
Gianni Gromo MD PhD, Switzerland
Prof. Dr Michael Heuser, Germany
Prof. Yelena Yesha, PhD, USA